Apyx Medical Corporation Stock

Equities

APYX

US03837C1062

Medical Equipment, Supplies & Distribution

Delayed Nasdaq 12:20:12 2024-04-19 pm EDT 5-day change 1st Jan Change
1.325 USD -3.99% Intraday chart for Apyx Medical Corporation -9.25% -49.43%
Sales 2024 * 49.94M Sales 2025 * 54.52M Capitalization 47.81M
Net income 2024 * -27M Net income 2025 * -25M EV / Sales 2024 * 0.96 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.88 x
P/E ratio 2024 *
-1.77 x
P/E ratio 2025 *
-1.98 x
Employees 252
Yield 2024 *
-
Yield 2025 *
-
Free-Float 82.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.55%
1 week-10.97%
Current month+1.47%
1 month-22.03%
3 months-30.65%
6 months-38.94%
Current year-47.33%
More quotes
1 week
1.26
Extreme 1.26
1.48
1 month
1.21
Extreme 1.21
1.90
Current year
1.21
Extreme 1.21
2.80
1 year
1.21
Extreme 1.21
7.97
3 years
1.21
Extreme 1.21
17.50
5 years
1.21
Extreme 1.21
17.50
10 years
1.21
Extreme 1.21
17.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 17-12-14
Founder 82 77-12-31
Director of Finance/CFO 56 Dec. 03
Members of the board TitleAgeSince
Founder 82 77-12-31
Director/Board Member 77 11-03-14
Director/Board Member 63 18-03-08
More insiders
Date Price Change Volume
24-04-19 1.325 -3.99% 7 082
24-04-18 1.38 +4.55% 66,774
24-04-17 1.32 -5.04% 89,880
24-04-16 1.39 +0.72% 26,856
24-04-15 1.38 -5.48% 82,830

Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT

More quotes
Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and OEM. The Advanced Energy segment's product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It is focused on the cosmetic surgery market where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue to achieve their desired results. Its product lines consist of a multifunction generator, a handpiece and a supply of helium gas. The OEM segment leverages its expertise in the design, development and manufacturing of electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers through original equipment manufacturing agreements, as well as start-up companies with the need for its energy-based designs.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.38 USD
Average target price
3.625 USD
Spread / Average Target
+162.68%
Consensus